ORAMED PHARMACEUTICALS INC. Quarterly Nonoperating Income (Expense) in USD from Q3 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2022 to Q3 2024.
  • Oramed Pharmaceuticals Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$15.4M, a 3645% decline year-over-year.
  • Oramed Pharmaceuticals Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $22.3M.
  • Oramed Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2023 was $22.9M, a 680% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $22.3M -$15.4M -$15.9M -3645% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $38.1M $14.2M +$11.8M +474% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $26.4M $5.09M +$3.49M +219% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $22.9M $18.4M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $435K -$601K -58% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.48M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $1.6M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $1.04M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.